Lanham O'Dell & Company’s Johnson & Johnson JNJ Stock Holding History

Lanham O'Dell & Company’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$301K	Hold	1,454	–	–	0.09%	23
2025 Q3	$270K	Hold	1,454	–	–	0.09%	27
2025 Q2	$222K	Buy	1,454 +168	+13%	+$25.8K	0.09%	32
2025 Q1	$213K	Buy	+1,286	New	+$201K	0.12%	28
2023 Q1	–	Sell	-1,495	Closed	-$264K	–	19
2022 Q4	$264K	Buy	+1,495	New	+$258K	0.58%	16

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lanham O'Dell & Company's JNJ Position: Q4 2025 in Review

Lanham O'Dell & Company held its Johnson & Johnson (JNJ) position steady in Q4 2025 at 1,454 shares worth $301K. The position accounts for 0.09% of the portfolio, ranked #23.

Lanham O'Dell & Company first reported a position in JNJ in Q4 2022 and has held it in 5 quarters since. 4,521 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

Lanham O'Dell & Company held 1,454 shares of Johnson & Johnson worth $301K as of Q4 2025.
Lanham O'Dell & Company left its Johnson & Johnson share count unchanged in Q4 2025.
Johnson & Johnson made up 0.09% of Lanham O'Dell & Company's portfolio in Q4 2025, its #23 holding.
Lanham O'Dell & Company first reported a position in Johnson & Johnson in Q4 2022 and has held it in 5 quarters since.
4,521 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Lanham O'Dell & Company's 13F filing for Q4 2025, filed 12 Jan 2026.